SHR0410 / Jiangsu Hengrui Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SHR0410 / Jiangsu Hengrui Pharma
NCT03493191: A Single Dose Study of SHR0410 in Healthy Male Participants

Completed
1
48
RoW
0.5μg/kg SHR0410, 1μg/kg SHR0410, 2μg/kg SHR0410, 5μg/kg SHR0410, 10μg/kg SHR0410, 20μg/kg SHR0410
Atridia Pty Ltd., Linear Clinical Research
Acute Pain
06/18
07/18
NCT03857568: A Trial of SHR0410 Injection in Hemodialysis Participants.

Completed
1
8
RoW
SHR0410, Placebo
Atridia Pty Ltd.
Pruritus
11/19
11/19
NCT04099927: A Study of SHR4010 in Patients With Hemodialysis

Completed
1
12
RoW
SHR0410, KOR agonist
Jiangsu HengRui Medicine Co., Ltd.
Pruritus
04/20
06/20
NCT04317209: A Study of SHR0410 in Hemodialysis Patients With Pruritus

Unknown status
1
54
RoW
SHR0410, KOR agonist, Placebo
Jiangsu HengRui Medicine Co., Ltd.
Pruritus
12/20
12/20

Download Options